nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ARB and Cardioprotection
|
Akazawa, Hiroshi |
|
2012 |
27 |
2 |
p. 155-160 |
artikel |
2 |
Asialoerythropoietin Exerts Stronger Angiogenic Activity than Erythropoietin Via its Binding Affinity to Tissue
|
Yanagawa, Takao |
|
2013 |
27 |
2 |
p. 117-124 |
artikel |
3 |
Ataluren: Time for a ‘No-Nonsense’ Approach to Heart Diseases
|
Loudon, John A. |
|
2013 |
27 |
2 |
p. 181-182 |
artikel |
4 |
Cardioprotection—Time to Take Into Account Clinical Complexity: The Case of Antiplatelet Agents
|
Roubille, François |
|
2013 |
27 |
2 |
p. 105-107 |
artikel |
5 |
Chymase Inhibition and Cardiovascular Protection
|
Tojo, Hideaki |
|
2013 |
27 |
2 |
p. 139-143 |
artikel |
6 |
It is Time to Reconsider the Cardiovascular Protection Afforded by RAAS Blockade - Overview of RAAS Systems
|
Tsukamoto, Osamu |
|
2011 |
27 |
2 |
p. 133-138 |
artikel |
7 |
Liposomal Amiodarone Augments Anti-arrhythmic Effects and Reduces Hemodynamic Adverse Effects in an Ischemia/Reperfusion Rat Model
|
Takahama, Hiroyuki |
|
2013 |
27 |
2 |
p. 125-132 |
artikel |
8 |
Parathyroid Hormone, A Crucial Mediator of Pathologic Cardiac Remodeling in Aldosteronism
|
Rutledge, Michael R. |
|
2012 |
27 |
2 |
p. 161-170 |
artikel |
9 |
RAAS Inhibitors and Cardiovascular Protection in Large Scale Trials
|
Lueder, Thomas G. von |
|
2012 |
27 |
2 |
p. 171-179 |
artikel |
10 |
Renin Inhibitors and Cardiovascular and Renal Protection: An Endless Quest?
|
Azizi, Michel |
|
2012 |
27 |
2 |
p. 145-153 |
artikel |
11 |
Two Classes of Anti-Platelet Drugs Reduce Anatomical Infarct Size in Monkey Hearts
|
Yang, Xi-Ming |
|
2013 |
27 |
2 |
p. 109-115 |
artikel |